Chromoendoscopy for inflammatory bowel disease Jan. 09, 2017 Overview Show transcript Overview Michael F. Picco, M.D., Ph.D., and Michael B. Wallace, M.D., gastroenterologists at Mayo Clinic's campus in Jacksonville, Florida, demonstrate a simplified technique for application of indicarmine and other staining agents for surveillance in inflammatory bowel disease. Receive Mayo Clinic news in your inbox. Sign up Related ContentArticleExamining clinical and genetic factors that impact response to anti-TNF agents in patients with IBDArticleResearch establishes strong association between family history and increased risk of colorectal cancer in patients with inflammatory bowel diseasesArticleInflammatory bowel disease biobank research update VID-20480174 Medical Professionals Chromoendoscopy for inflammatory bowel disease